# Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

> **NCT00877591** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 63 (actual)

## Conditions studied

- Opioid Dependency
- HIV Infections

## Interventions

- **DRUG:** Fosamprenavir/Ritonavir
- **DRUG:** Darunavir/Ritonavir
- **DRUG:** Rifampin
- **DRUG:** Rifabutin
- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT00877591
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2014-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00877591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00877591, "Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00877591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*